Connecticut Children's Medical Center

Connecticut Children's Medical Center was paid $248.94M by Medicaid between Jan 2018 and Dec 2024, across 466 billing codes. Its largest line is 99285, emergency room visit (most serious) — 17% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	342,835	$30.79M
2019	329,279	$34.42M
2020	260,453	$28.37M
2021	384,627	$36.54M
2022	391,330	$39.74M
2023	389,592	$39.54M
2024incomplete	370,431	$39.55M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	17%	21,914	19,070	$42.76M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	9.5%	100,630	89,393	$23.73M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	8.9%	52,550	45,752	$22.14M
J1745	Injection, infliximab, excludes biosimilar, 10 mg	6.1%	7,571	6,359	$15.13M
42820	Tonsillectomy and adenoidectomy; younger than age 12	5.8%	2,838	2,685	$14.46M
99282	Emergency department visit for the evaluation and management, low to moderate severity	4.6%	83,765	75,034	$11.37M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	2.8%	92,916	33,336	$6.89M
J3380	Injection, vedolizumab, intravenous, 1 mg	2.8%	1,586	1,088	$6.87M
95810	Polysomnography; sleep staging with 4 or more additional parameters	2.2%	5,598	5,332	$5.41M
G0379	Direct admission of patient for hospital observation care	1.8%	2,065	1,835	$4.45M
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	1.7%	46,693	24,284	$4.29M
97530	Therapeutic activities, direct patient contact, each 15 minutes	1.7%	84,103	32,222	$4.18M

454 more codes

42830		1.6%	1,492	$4.02M
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	1.4%	3,896	$3.48M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	1.2%	9,727	$3.03M
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	1.2%	6,320	$2.88M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	1.1%	5,876	$2.85M
95782		1.1%	2,810	$2.81M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	1.1%	4,422	$2.77M
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	19,435	$2.40M
44970		<1%	443	$2.20M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	12,244	$2.18M
93304		<1%	3,814	$1.93M
92587		<1%	7,081	$1.92M
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	14,778	$1.91M
G0330	Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room	<1%	1,361	$1.90M
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	14,701	$1.71M
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	11,898	$1.70M
71046	Radiologic examination, chest; 2 views	<1%	24,198	$1.68M
92523		<1%	7,034	$1.67M
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	<1%	731	$1.66M
92579		<1%	12,995	$1.50M
54161		<1%	1,082	$1.47M
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	3,443	$1.44M
76770		<1%	12,824	$1.39M
93975		<1%	7,268	$1.39M
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	8,211	$1.21M
41899	Unlisted procedure, dentoalveolar structures	<1%	4,836	$1.20M
94010		<1%	8,829	$1.15M
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	1,179	$1.10M
92552		<1%	8,854	$858K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	10,811	$831K
92610		<1%	3,795	$823K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	3,643	$787K
92526		<1%	8,054	$727K
96361	Intravenous infusion, hydration; each additional hour	<1%	16,322	$723K
92582		<1%	5,529	$719K
97161		<1%	9,475	$694K
94060		<1%	2,495	$686K
97162		<1%	9,394	$669K
36430		<1%	2,038	$647K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	34,431	$633K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	13,078	$596K
95812		<1%	2,228	$586K
95716		<1%	626	$559K
97165		<1%	6,457	$552K
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	<1%	7,909	$522K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	4,378	$521K
96415		<1%	7,538	$516K
49452		<1%	952	$494K
96375	Therapeutic injection; each additional sequential IV push	<1%	11,739	$439K
73100		<1%	5,527	$425K
72170		<1%	4,421	$423K
70450	Computed tomography, head or brain; without contrast material	<1%	3,934	$417K
92553		<1%	3,085	$408K
73610		<1%	8,485	$383K
72197		<1%	518	$380K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	4,562	$373K
95819		<1%	1,430	$371K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	1,587	$361K
77072		<1%	3,614	$354K
96409		<1%	1,616	$348K
93308		<1%	1,589	$347K
92611		<1%	1,524	$345K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	4,471	$345K
C9399	Unclassified drugs or biologicals	<1%	6,313	$340K
95951		<1%	424	$338K
76825		<1%	641	$327K
73564		<1%	4,946	$279K
95700		<1%	1,479	$275K
72081		<1%	4,464	$269K
92652		<1%	1,158	$268K
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	489	$260K
73090		<1%	5,098	$249K
74240		<1%	1,724	$232K
24538		<1%	46	$231K
97166		<1%	2,765	$230K
74230		<1%	1,575	$227K
V5090	Dispensing fee, unspecified hearing aid	<1%	443	$223K
73070		<1%	2,848	$216K
73140		<1%	4,857	$215K
73630		<1%	5,968	$214K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	4,827	$213K
72082		<1%	2,038	$212K
92585		<1%	891	$202K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	4,723	$202K
73590		<1%	4,599	$197K
76536		<1%	2,930	$193K
73080		<1%	4,111	$191K
76885		<1%	2,419	$186K
31526		<1%	110	$179K
73560		<1%	3,506	$177K
54640		<1%	67	$170K
76506		<1%	1,686	$169K
76881		<1%	1,527	$153K
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	452	$148K
95714		<1%	307	$142K
71045	Radiologic examination, chest; single view	<1%	2,611	$140K
73110		<1%	3,659	$140K
86900		<1%	4,343	$138K
77073		<1%	1,541	$136K
74018		<1%	3,844	$131K
92508	Group treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	1,851	$121K
75561		<1%	218	$113K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	307	$111K
95816		<1%	454	$111K
73130		<1%	3,501	$109K
97116		<1%	2,163	$107K
25605		<1%	113	$107K
97113		<1%	1,636	$106K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	5,075	$105K
96367		<1%	2,009	$99K
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	731	$94K
96450		<1%	313	$94K
83036	Hemoglobin; glycosylated (A1C)	<1%	10,834	$81K
72100		<1%	1,371	$78K
74183		<1%	544	$77K
76870		<1%	2,916	$77K
73521		<1%	1,681	$75K
73030		<1%	1,954	$75K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	13,297	$74K
72141		<1%	238	$73K
73552		<1%	1,982	$71K
V5264	Ear mold/insert, not disposable, any type	<1%	1,679	$71K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	21,939	$69K
73000		<1%	1,387	$68K
93017		<1%	302	$67K
73562		<1%	1,144	$61K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	39,151	$58K
74019		<1%	9,989	$58K
92522		<1%	242	$57K
92557		<1%	485	$56K
82947		<1%	16,229	$51K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	500	$49K
V5261	Hearing aid, digital, binaural, bte	<1%	71	$48K
97533		<1%	688	$45K
10060		<1%	261	$45K
0001A		<1%	1,188	$42K
92555		<1%	16,926	$40K
0002A		<1%	1,051	$39K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	208	$39K
97542		<1%	595	$38K
20680		<1%	14	$37K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	798	$35K
85246		<1%	1,461	$34K
94667		<1%	704	$33K
92567		<1%	24,694	$32K
51784		<1%	368	$29K
82728		<1%	3,954	$29K
73060		<1%	788	$28K
95811		<1%	28	$28K
90375		<1%	19	$27K
G0378	Hospital observation service, per hour	<1%	16,695	$27K
76800		<1%	251	$26K
67311		<1%	13	$26K
97535	Self-care/home management training, each 15 minutes	<1%	5,132	$23K
92651		<1%	113	$23K
80053	Comprehensive metabolic panel	<1%	10,294	$23K
L4350	Ankle control orthosis, stirrup style, rigid, includes any type interface (e.g., pneumatic, gel), prefabricated, off-the-shelf	<1%	608	$22K
73660		<1%	618	$20K
70360		<1%	627	$20K
87631		<1%	5,427	$19K
24640		<1%	84	$19K
77077		<1%	222	$19K
73620		<1%	620	$18K
76000		<1%	602	$18K
71250		<1%	171	$18K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	1,953	$17K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	1,957	$17K
86902		<1%	101	$16K
95813		<1%	54	$14K
82962		<1%	16,421	$14K
29105		<1%	89	$13K
83550		<1%	2,394	$13K
85240		<1%	1,145	$13K
76641		<1%	193	$13K
97014		<1%	290	$12K
76857		<1%	144	$11K
74455		<1%	46	$11K
92593		<1%	663	$10K
83540		<1%	2,469	$10K
74210		<1%	41	$9K
85045		<1%	5,202	$9K
74220		<1%	55	$7K
86923		<1%	882	$7K
95953		<1%	12	$7K
L1830	Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf	<1%	134	$6K
72156		<1%	26	$6K
94664		<1%	48	$6K
72040		<1%	252	$5K
85730		<1%	6,119	$5K
84443	Thyroid stimulating hormone (TSH)	<1%	2,352	$5K
V5257	Hearing aid, digital, monaural, bte	<1%	18	$5K
0071A		<1%	121	$5K
72070		<1%	128	$5K
J3490	Unclassified drugs	<1%	284,454	$4K
0072A		<1%	102	$4K
64615		<1%	13	$4K
83021		<1%	463	$4K
73600		<1%	68	$4K
70491		<1%	12	$4K
82784		<1%	958	$4K
J0134	Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg	<1%	11,305	$4K
90675		<1%	14	$4K
72157		<1%	40	$4K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	422	$4K
92586		<1%	27	$4K
85610		<1%	6,353	$3K
96411		<1%	39	$3K
93325		<1%	13,215	$3K
74712		<1%	13	$3K
85250		<1%	275	$3K
77080		<1%	41	$3K
83735		<1%	7,062	$3K
94726		<1%	28	$3K
76826		<1%	12	$3K
85384		<1%	590	$3K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	7,854	$3K
12001		<1%	1,337	$3K
72158		<1%	41	$2K
76010		<1%	1,171	$2K
92591		<1%	76	$2K
12011		<1%	2,114	$2K
0012A		<1%	142	$2K
72146		<1%	44	$2K
85027		<1%	2,378	$2K
J2704	Injection, propofol, 10 mg	<1%	28,268	$2K
83615		<1%	2,466	$2K
92602		<1%	14	$2K
72125	Computed tomography, cervical spine; without contrast material	<1%	76	$2K
76820		<1%	1,130	$2K
94644		<1%	1,337	$2K
81003		<1%	27,398	$2K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	1,163	$2K
14040		<1%	52	$2K
86780		<1%	155	$2K
36415	Collection of venous blood by venipuncture	<1%	1,207	$2K
77074		<1%	13	$2K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	8,927	$2K
84439		<1%	1,767	$2K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	6,342	$1K
92556		<1%	1,434	$1K
86140		<1%	14,308	$1K
88342		<1%	1,448	$1K
72083		<1%	12	$1K
84100		<1%	7,132	$1K
85652		<1%	5,727	$1K
81025		<1%	17,527	$1K
80047		<1%	803	$1K
73700		<1%	16	$1K
70486		<1%	13	$1K
97163		<1%	15	$1K
97167		<1%	14	$1K
76604		<1%	42	$1K
85007		<1%	852	$1K
82330		<1%	11,459	$1K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	4,944	$1K
85270		<1%	70	$974.70
76821		<1%	1,136	$967.53
0111A		<1%	59	$920.00
95012		<1%	1,052	$899.41
97032		<1%	14	$882.00
80048	Basic metabolic panel (calcium, ionized)	<1%	4,226	$864.61
J7030	Infusion, normal saline solution , 1000 cc	<1%	22,092	$859.17
82248		<1%	2,601	$849.33
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	1,501	$781.01
90686		<1%	201	$761.20
80076		<1%	5,057	$743.22
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	41,548	$731.94
J7050	Infusion, normal saline solution, 250 cc	<1%	37,085	$703.01
86665		<1%	380	$690.71
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	41,061	$689.92
82565		<1%	16,483	$672.73
L3908	Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf	<1%	40	$640.15
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	1,558	$639.64
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	37,697	$556.19
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	7,269	$537.91
J0690	Injection, cefazolin sodium, 500 mg	<1%	9,023	$532.05
85014		<1%	1,922	$481.11
0112A		<1%	27	$480.00
76376		<1%	844	$380.86
82977		<1%	5,683	$377.83
85041		<1%	264	$365.75
87077		<1%	2,726	$363.89
76827		<1%	641	$363.03
82803		<1%	2,840	$361.29
87086	Culture, bacterial; quantitative colony count, urine	<1%	10,835	$356.48
83880		<1%	836	$330.09
92592		<1%	31	$323.64
85018		<1%	314	$323.18
J2270	Injection, morphine sulfate, up to 10 mg	<1%	15,906	$307.11
82247		<1%	1,568	$301.54
86664		<1%	343	$290.42
86850		<1%	4,321	$280.37
84145		<1%	2,163	$274.88
80061	Lipid panel	<1%	25	$274.15
J7120	Ringers lactate infusion, up to 1000 cc	<1%	17,873	$264.16
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	18,525	$261.08
86663		<1%	274	$249.08
84702		<1%	275	$236.07
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	1,081	$231.76
82010		<1%	64	$230.10
83690		<1%	4,610	$221.48
87070		<1%	2,446	$208.48
L3670	Shoulder orthosis, acromio/clavicular (canvas and webbing type), prefabricated, off-the-shelf	<1%	13	$197.16
87186		<1%	2,060	$194.55
J7699	Noc drugs, inhalation solution administered through dme	<1%	746	$192.20
82435		<1%	15,780	$184.82
83605		<1%	856	$183.15
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	2,104	$179.07
85230		<1%	13	$171.00
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	938	$157.40
87040		<1%	3,689	$156.92
J1170	Injection, hydromorphone, up to 4 mg	<1%	3,147	$153.52
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	2,817	$153.52
J3535	Drug administered through a metered dose inhaler	<1%	10,643	$143.32
82150		<1%	2,040	$141.11
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	27,190	$131.84
84520		<1%	15,856	$130.25
84295		<1%	16,270	$126.61
86901		<1%	4,326	$125.91
82374		<1%	15,680	$124.93
82570		<1%	52	$113.62
J1720	Injection, hydrocortisone sodium succinate, up to 100 mg	<1%	191	$110.64
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	7,187	$110.42
87205		<1%	2,419	$106.06
84132		<1%	16,294	$105.55
86038		<1%	34	$103.86
88304		<1%	1,942	$102.19
87081		<1%	5,507	$96.68
A9585	Injection, gadobutrol, 0.1 ml	<1%	12,159	$83.24
82550		<1%	1,312	$80.22
87328		<1%	510	$80.15
82105		<1%	12	$80.10
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	2,199	$75.00
86364		<1%	86	$66.12
J7644	Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram	<1%	9,242	$58.32
84450		<1%	2,107	$56.20
86618		<1%	351	$48.81
85379		<1%	80	$48.60
J7611	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg	<1%	12,588	$42.75
82040		<1%	830	$41.95
76828		<1%	12	$40.26
36416		<1%	11,637	$35.49
29125		<1%	266	$32.27
84460		<1%	2,068	$25.55
81001		<1%	4,556	$23.71
J1836	Injection, metronidazole, 10 mg	<1%	150	$23.40
84484		<1%	923	$22.00
90472	Immunization administration, each additional vaccine (list separately)	<1%	12	$22.00
87184		<1%	376	$19.78
87340		<1%	70	$19.74
84550		<1%	304	$17.84
87075		<1%	167	$16.99
80069		<1%	28	$16.60
J3480	Injection, potassium chloride, per 2 meq	<1%	8,252	$15.01
J8499	Prescription drug, oral, non chemotherapeutic, nos	<1%	18,558	$14.19
82140		<1%	12	$13.92
86706		<1%	48	$10.26
89050		<1%	99	$8.47
A4606	Oxygen probe for use with oximeter device, replacement	<1%	3,793	$5.00
86308		<1%	143	$4.94
Q0163	Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen	<1%	9,292	$4.19
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	10,667	$4.09
84075		<1%	955	$1.44
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	4,711	$0.18
A4217	Sterile water/saline, 500 ml	0%	1,251	$0.00
L8699	Prosthetic implant, not otherwise specified	0%	3,167	$0.00
96376		0%	2,887	$0.00
93320		0%	6,457	$0.00
90656		0%	26	$0.00
J1815	Injection, insulin, per 5 units	0%	982	$0.00
J7042	5% dextrose/normal saline (500 ml = 1 unit)	0%	598	$0.00
J0330	Injection, succinylcholine chloride, up to 20 mg	0%	582	$0.00
94760		0%	319	$0.00
J9250	Methotrexate sodium, 5 mg	0%	125	$0.00
C1769	Guide wire	0%	872	$0.00
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	0%	4,678	$0.00
J7626	Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg	0%	143	$0.00
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	0%	876	$0.00
J2060	Injection, lorazepam, 2 mg	0%	383	$0.00
J7799	Noc drugs, other than inhalation drugs, administered through dme	0%	552	$0.00
Q9965	Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml	0%	565	$0.00
91307		0%	226	$0.00
J2765	Injection, metoclopramide hcl, up to 10 mg	0%	566	$0.00
96111		0%	290	$0.00
86803		0%	125	$0.00
51798		0%	78	$0.00
96112		0%	315	$0.00
12002		0%	72	$0.00
12013		0%	26	$0.00
J2003	Injection, lidocaine hydrochloride, 1 mg	0%	94	$0.00
99156		0%	61	$0.00
82553		0%	142	$0.00
76377		0%	344	$0.00
J7060	5% dextrose/water (500 ml = 1 unit)	0%	150	$0.00
A9150	Non-prescription drugs	0%	11,694	$0.00
85660		0%	37	$0.00
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	0%	186	$0.00
82533		0%	17	$0.00
B4088	Gastrostomy/jejunostomy tube, low-profile, any material, any type, each	0%	159	$0.00
82077		0%	139	$0.00
87046		0%	71	$0.00
81015		0%	64	$0.00
94200		0%	39	$0.00
51600		0%	32	$0.00
86920		0%	21	$0.00
84703		0%	13	$0.00
91301		0%	154	$0.00
J0461	Injection, atropine sulfate, 0.01 mg	0%	40	$0.00
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	0%	57	$0.00
J7070	Infusion, d5w, 1000 cc	0%	224	$0.00
51741		0%	137	$0.00
98960		0%	748	$0.00
93321		0%	5,310	$0.00
94645		0%	277	$0.00
91311		0%	86	$0.00
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	0%	307	$0.00
96113		0%	377	$0.00
J7510	Prednisolone oral, per 5 mg	0%	441	$0.00
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	0%	1,378	$0.00
J2274	Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg	0%	477	$0.00
80143		0%	205	$0.00
75565		0%	240	$0.00
76937		0%	88	$0.00
J0171	Injection, adrenalin, epinephrine, 0.1 mg	0%	1,394	$0.00
J9370	Vincristine sulfate, 1 mg	0%	1,587	$0.00
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	0%	5,887	$0.00
J7676	Pentamidine isethionate, inhalation solution, compounded product, administered through dme, unit dose form, per 300 mg	0%	356	$0.00
J0780	Injection, prochlorperazine, up to 10 mg	0%	290	$0.00
J2919	Injection, methylprednisolone sodium succinate, 5 mg	0%	382	$0.00
92595		0%	155	$0.00
J7610	Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg	0%	866	$0.00
J1171	Injection, hydromorphone, 0.1 mg	0%	169	$0.00
91300		0%	2,239	$0.00
88313		0%	33	$0.00
L8612	Aqueous shunt	0%	114	$0.00
82375		0%	15	$0.00
80179		0%	181	$0.00
51701		0%	79	$0.00
94729		0%	12	$0.00
81002		0%	170	$0.00
C8909	Magnetic resonance angiography with contrast, chest (excluding myocardium)	0%	26	$0.00
Q9961	High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml	0%	136	$0.00
S0080	Injection, pentamidine isethionate, 300 mg	0%	16	$0.00
87427		0%	57	$0.00
J0688	Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg	0%	28	$0.00
76882		0%	12	$0.00
87045		0%	57	$0.00
92594		0%	13	$0.00
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	0%	13	$0.00
A6250	Skin sealants, protectants, moisturizers, ointments, any type, any size	0%	77	$0.00
J0136	Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg	0%	2,947	$0.00
86705		0%	13	$0.00
69200		0%	12	$0.00
A4565	Slings	0%	26	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialJACOBSEN, RACHAEL (REVENUE CYCLE SYSTEMS ANALYST)

Parent organizationCCMC CORPORATION